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omplexesAbstract Coordination compounds of Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) with the Schiff base
obtained through the condensation of L1 and L2 (L1 – obtained through the condensation of 4-ami-
noantipyrine with furfuraldehyde and L2 – derived from 2-aminobenzothiazole and 3-nitrobenzalde-
hyde)were synthesized under reﬂux conditions. The newly formed complexeswere characterized using
elemental analysis,magnetic susceptibility,molar conductance, 1HNMR,UV–Vis., IRandESR tech-
niques. Cyclic voltammogram of the complexes in DMSO solution at 300 K was recorded and their
salient features were summarized. The X-band ESR spectrum of the copper complex in DMSO solu-
tion at 300 and 77 Kwas recorded.The in vitro biological screening of the investigated compoundswas
tested against the bacterial species, and fungal species by disc diffusion method. The antimicrobial
activity of metal complexes was dependent on the microbial species tested, ligand and the metal salts
used. A comparative study of inhibition values of Schiff bases and their complexes indicates that the
complexes exhibit higher antimicrobial activity than the free ligands. The DNA binding studies were
performed for the complexes using cyclic voltammetry and electronic absorption spectra. Superoxide
dismutase activity of these complexes has also been examined.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
During the past few decades, considerable attention has been
paid to the chemistry of metal complexes of Schiff basesJoseph).
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. Arabian Journal of Chemistry (2containing nitrogen and other donor atoms (Djebbar et al.,
1997; Bhattacharya et al., 1998; He et al., 1999; Wu et al.,
2001; Chatterjee et al., 2004; Minu et al., 2004). This may be
attributed to their stability, biological activity (Liu et al., 1996)
and potential applications in many ﬁelds such as oxidation
catalysis (Djebbar et al., 1998), electrochemistry (Hamada,
1997) etc. Schiff base complexes showed photochromism and
thermochromism in the solid state by proton transfer from the
(O) to the imine (N) atoms in the ligand molecule (Abd El-Wa-
hab, 2007).
2-Aminobenzothiazole is found as structural unit in anti-
oxidants, anti-inﬂammatory, herbicides, antibiotics, thermo-ing Saud University.
ased SOD mimetic therapeutic agents: Synthesis, characterization and
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2 J. Joseph, G. Ayisha Bibin Raniplastic polymers, ﬂavouring, and odour agents and in the lucif-
erine responsible for the bioluminenescence of ﬁre ﬂies (Rama-
lingam et al., 2004; Zitouni et al., 2004; Neelakandan et al.,
2008). The coordinating property of 4-aminoantipyrine has
been modiﬁed to give a ﬂexible ligand system, formed by con-
densation with a variety of reagents like aldehydes, ketones,
thiosemicarbazides carbazides, etc. (Tudor Rosu et al., 2010).
The Schiff base of 4-aminoantipyrine and its complexes has
a variety of applications in biological, clinical, analytical and
pharmacological areas (Hitoshi et al., 1997; Punniyamurthy
et al., 1995; Trivedi et al., 1992). Mixed ligand complexes of
transition metals containing ligands with N, S or N, S, O do-
nors are known to exhibit interesting stereochemical, electro-
chemical and electronic properties (De Sousa et al., 1992;
Prabhakaran et al., 2005).
The metal complex-DNA interactions have received much
importance for the development of new metal-based chemo-
therapeutic drugs (Afrati et al., 2009). Transition metal com-
plexes have shown considerable attention as catalysts due to
their DNA binding and cleavage properties (Saglam et al.,
2002; Ji et al., 2001; Dupureur et al., 1997; Mesmaeker et al.,
1996; Norden et al., 1996; Khairul et al., 2009; Khan et al.,
2010) and ability to probe electron-transfer reactions involving
metalloproteins (Schoumacker et al., 2003). These metal com-
plexes can interact non-covalently with nucleic acids by inter-
calation, groove binding or external electrostatic binding
(Metcalfe et al., 2003; Deshpande et al., 2009; Zeglis et al.,
2007; Sastri et al., 2004). Among the above interactions, the
intercalative interaction of ligands with the DNA is very inter-
esting since many anti-cancer drugs and antibiotics show their
biological activities through DNA intercalation (Mariappan
et al., 2005, 2011). Several mixed ligand complexes have been
found to exhibit SOD mimetic activities which are related to
the ﬂexibilities of the geometric transformations around the
metal centres. Furthermore, low molecular weight compounds
with superoxide dismutase mimetic activity have potential use
as antioxidant pharmaceuticals in the treatment or prevention
of several diseases related with the overproduction of an unde-
sired O2. In particular, some mixed ligand complexes with
SOD mimetic activity have demonstrated to possess anti-
inﬂammatory activity, and anticarcinogenic and antimutagenic
effects (Oberley, 2005; Mitrunen et al., 2001).
With this considerations in mind, in this paper we have dis-
cussed the synthesis, characterization, DNA binding, biologi-
cal studies including SOD activity of mixed ligand complexes
containing a Schiff base L1 and L2 (L1 – obtained through
the condensation of 4-aminoantipyrine with furfuraldehyde
and L2 – derived from 2-aminobenzothiazole and 3-nitrobenz-
aldehyde) tuning up of biochemical potentials.
2. Materials and methods
2.1. Materials
All chemicals used in the present work viz, 4-aminoantipyrine,
furfuraldehyde, 2-aminobenzothiazole, 3-nitrobenzaldehyde,
Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) chlorides were of
analytical reagent grade (Merck). The solvents used in the
synthesis of the ligands and metal complexes were distilled
before use. Calf thymus DNA was purchased from Genie
Biolab, Bangalore, India.Please cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
biochemical studies of metal complexes. Arabian Journal of Chemistry (22.2. Instrumentation
The elemental analysis was performed using Elementar Vario
EL III Carlo Erba 1108. The amount of metal present in the me-
tal complexes was estimated using ammonium oxalate method
(Vogel 1978). IR spectra of the Schiff base ligands and their me-
tal complexes were recorded on Perkin–Elmer FT-IR 783 Spec-
trophotometer in 4000–300 cm1 range using KBr disc. 1H
NMR spectra were recorded on a Bruker Avance Dry
300 MHz FT-NMR Spectrometer in DMSO with TMS as the
internal reference. The FABmass spectrum of the Schiff base li-
gands and their complexes were recorded on a JEOL SX 102/
DA-6000 mass spectrometer/data system using argon/xenon
(6 kV, 10 mA) as the FAB gas. ESR spectra of the mixed ligand
copper complexwas recorded on aVarianE 112EPRSpectrom-
eter inDMSO solution both at room temperature (300 K) and at
liquid nitrogen temperature (77 K) using TCNE (tetracyanoeth-
ylene) as the g marker. Electronic absorption spectra of the
Schiff base ligands and their mixed ligand complexes were re-
corded in DMSO using a Systronics 2201 double beam UV–
Vis., spectrophotometer. Molar conductance of the metal com-
plexes was measured in DMSO solution using a coronation dig-
ital conductivity metre. The magnetic susceptibility values were
calculated using the relation leff = 2.83(vm T)
1/2. The diamag-
netic corrections were made by Pascal’s constant and
Hg[Co(SCN)4] was used as a calibrant. Electrochemical experi-
ments were performed on a CHI 604D electrochemical analysis
system with a three-electrode system consisting a glassy carbon
working electrode, Pt wire auxiliary electrode and Ag/AgCl ref-
erence electrode. Tetrabutylammoniumperchlorate (TBAP)was
used as the supporting electrolyte. All solutions were purged
withN2 for 30 min prior to each set of experiments. Calf thymus
DNA was purchased from Bangalore Genei (India). Tris–HCl
buffer solution used for binding studies was prepared using dou-
ble distilled water.3. Preparation
3.1. Preparation of ligands
The Schiff base ligands (L1, L2) were prepared according to
earlier reports, with slight modiﬁcations (Ismail et al., 1997;
Vicini et al., 2003)
L1: The ligand (L1) was prepared as reported previously.
L2: The Schiff base (L2) was prepared by the condensation
of 2-aminobenzothiazole (1 mM) and 3-nitrobenzaldehyde
(1 mM) dissolved in 30 mL absolute EtOH, in the presence
of few drops of piperidine. The resulting mixture was stirred
well, reﬂuxed for 7 h. The mixture was concentrated to its half
volume then cooled. Petroleum ether was added to the reaction
mixture dropwise until a product began to precipitate. The
formed product was ﬁltered off, washed several times with
EtOH, recrystallized from EtOH.
3.2. Preparation of metal complexes
An ethanolic solution of metal (M = FeCl3.6H2O, CoCl2.6-
H2O, NiCl2.6H2O, CuCl2.2H2O and ZnCl2) (1 mM) chlorides
was stirred with an ethanolic solution of ligand(s) (L1/L2)
(1 mM) and the resultant mixture was reﬂuxed for ca. 6–8 h.ased SOD mimetic therapeutic agents: Synthesis, characterization and
013), http://dx.doi.org/10.1016/j.arabjc.2013.07.024
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Scheme 1 Schematic route for synthesis of Schiff base ligands and its metal complexes.
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water bath. The solid complex precipitated was ﬁltered,
washed thoroughly with ethanol and dried in vacuum. The
schematic route for the synthesis of Schiff base ligands and
their metal complexes is given in Scheme 1.
3.3. DNA binding experiments
Interaction of the complex with calf thymus DNA has been
studied by recording electronic absorption spectra. A solution
of CT-DNA in 5 mM Tris–HCl/50 mM NaCl (pH 7.0) gave aPlease cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
biochemical studies of metal complexes. Arabian Journal of Chemistry (2ratio of UV absorbance at 260 and 280 nm (A260/A280) of 1.8–
1.9, indicating that the DNA is sufﬁciently free of proteins. A
concentrated stock solution of DNA was prepared in 5 mM
Tris–HCl/50 mM NaCl in water at pH 7.0 and the concentra-
tion of CT-DNA was determined per nucleotide by taking the
absorption coefﬁcient (6600 dm3 mol1 cm1) at 260 nm.
Stock solutions are stored at 4 C and were used after no more
than 4 days. Doubly distilled water was used to prepare buffer
solutions. Solutions were prepared by mixing the complex and
CT-DNA in DMF medium. After the equilibrium reached ca.
5 min the spectra were recorded against an analogous blankased SOD mimetic therapeutic agents: Synthesis, characterization and
013), http://dx.doi.org/10.1016/j.arabjc.2013.07.024
4 J. Joseph, G. Ayisha Bibin Ranisolution containing the same concentration of DNA. UV spec-
tral data were ﬁtted into Eq. (1) to obtain the intrinsic binding
constant (Kb)
½DNA=ðea  efÞ ¼ ½DNA=ðeb  efÞ þ Kbðeb  efÞ ð1Þ
where [DNA] is the concentration of DNA in base pairs, ea, eb
and ef are apparent extinction coefﬁcient (Aobs/[M]), the extinc-
tion coefﬁcient for the metal (M) complex in the fully bound
form and the extinction coefﬁcient for free metal (M), respec-
tively. A plot of [DNA]/ (ea ef) versus [DNA] gave a slope of 1/
(eb- ef) and Y-intercept equal to 1/Kb(eb- ef); Kb is the ratio of
the intercept.
3.4. Antimicrobial activity
The in vitro evaluation of antimicrobial activity was carried
out. The prepared compounds were tested against some fungi
and bacteria to provide the minimum inhibitory concentration
(MIC) for each compound. MIC is the lowest concentration of
the solution to inhibit the growth of a test organism. The
in vitro biological screening effects of the investigated com-
pounds were tested against the bacterial species Staphylococcus
aureus, Escherichia coli, Klebsiella pneumoniae, Salmonella ty-
phi and Pseudomonas aeruginosa and fungal species Aspergillus
niger, Rhizopus stolonifer, Aspergillus ﬂavus, Rhizoctonia batai-
cola and Candida albicans by disc diffusion method. One day
prior to the experiment, the bacterial and fungal cultures were
inoculated in nutrient broth (inoculation medium) and incu-
bated overnight at 37 C. Inoculation medium containing
24 h grown culture was added aseptically to the nutrient med-
ium and mixed thoroughly to get uniform distribution. This
solution was poured (25 ml in each dish) into petri dishes
and then allowed to attain room temperature. Wells (6 mm
in diameter) were cut in the agar plates using proper sterile
tubes. Then, the wells were ﬁlled up to the surface of agar with
0.1 ml of the test compounds dissolved in DMSO (200 lg/ml).
The plates were allowed to stand for an hour in order to facil-
itate the diffusion of the drug solution. Then the plates were
incubated at 37 C for 24 h for bacteria and 48 h for fungi
and the diameter of the inhibition zones was measured. Mini-
mum inhibitory concentrations (MICs) were detected by the
serial dilution method. The lowest concentration (lg/ml) of
compounds, which inhibits the growth of bacteria after 24 h
incubation at 37 C, and of fungi after 72 h incubation at
37 C was taken as the MIC.
3.5. Superoxide dismutase (SOD) activity
In vitro SOD activity was measured using alkaline DMSO as a
source of superoxide radical ion (O2 ) and nitrobluetetrazoli-
um (NBT) as O2 scavenger (Bhirud et al., 1990, 1991). In gen-
eral, 400 lL of the sample to be assayed was added to a
solution containing 2.1 mL of 0.2 M potassium phosphate buf-
fer (pH 7.8) and 1 mL of 56 lM NBT. The tubes were kept in
ice for 20 min and then 1.5 mL of alkaline DMSO solution was
added while stirring. The absorbance was then monitored at
540 nm against a sample prepared under a similar condition
except that NaOH was absent in DMSO. The measure of
SOD activity, expressed as IC50 is the concentration of the sub-
strate or complex which causes 50% inhibition of the reduc-
tion of NBT.Please cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
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The Schiff base ligands and their complexes have been synthe-
sized and characterized by spectral and elemental data. The
colour, analytical data, molar conductance and magnetic mo-
ment are given in Table 1. The elemental analyses of the Schiff
base ligands and their complexes supported the present com-
position of the complexes. The molar conductance of all
complexes was measured in DMSO using 10–3 M solutions
at room temperature. The conductance (Table 1) values are
fund to be in the range of 8–51 (O1cm2 mol1), indicating that
all complexes are 1:1 electrolytic in nature except iron complex
(non electrolytic in nature) (Geary, 1971). All complexes are
air stable. These complexes are found to be soluble in
chloroform, dimethylformide, tetrahydrofuran and
dimethylsulphoxide.
4.1. 4.1.1H NMR Spectra
The ligand (L1) shows the following signals and their assign-
ments are given below: phenyl multiplet at 7.0–7.5 d (5H), –
CH‚N at 7.8 (due to furfuryl moiety), –C–CH3 at 2.2 d, N–
CH3 at 1.5 d. The ligand (L
2) shows the following signals
and their assignments are given below: phenyl multiplet at
7.5–8.1 d (8H), –CH‚N at 7.9 d (due to phenyl moiety).
The azomethine proton (–CH‚N) signal in the spectrum of
zinc complex is shifted down ﬁeld (7.6 and 7.7 ppm) compared
to the free ligands, suggesting deshielding of the azomethine
group due to the coordination with metal ion. All protons were
found to be in similar regions.
4.2. IR spectra
In order to study the bonding mode of the Schiff base to the
metal complexes, the IR spectra of the free ligands were com-
pared with the spectrum of the complexes. In the ligand L1, the
absorption band at 1647 cm1 may be assigned to m(C‚O).
The absorption band is shifted to a lower wave number 20–
32 cm1 in the spectra of all complexes suggesting the involve-
ment of the pyrazolone oxygen in chelation.
The strong absorption bands located at 1602 and
1629 cm1 in the spectrum of the free ligands L1 and L2 are
attributed to m(–CH‚N) vibrations. These bands are shifted
(by 10–40 cm1) towards lower frequencies in the spectra
of all complexes, which clearly suggested that complexation
has taken place through the nitrogen atom of the azomethine
group.
In the case L2, the bands at 1458 and 1155 cm1 are char-
acteristic of the m(C–S) of the thiazole ring. This band remains
at the same position in the spectra of the Schiff base as well as
in the case of its complexes revealing that sulphur atom of the
thiazole ring is not taking part in the coordinate bond forma-
tion with the metal ions.
The IR spectra of all complexes show another band in the
region 374–378 cm1, which may be due to M–Cl stretching
vibrations. Furthermore, the IR spectra of the Fe(III) show
another band in the region 351 cm1, which may be due to
t(Fe–Cl) vibrations. The IR spectra of the metal complexes
also showed some new bands in the region 478–453 and 447–
410 cm1 which may be assigned to m(M–O) and m(M–N)ased SOD mimetic therapeutic agents: Synthesis, characterization and
013), http://dx.doi.org/10.1016/j.arabjc.2013.07.024
Table 2 IR spectral data (cm1) for the free ligands and their metal complexes.
Compound mC‚O (cm
1) mC‚N (furfuryl moiety) (cm
1) mC‚N (phenyl moiety) (cm
1) mM–O (cm
1) mM–N (cm
1) mM–Cl (cm
1)
L1 1647 1602 – – – –
L2 – 1629 – – – –
[CuL1L2Cl]Cl 1634 1583 1576 457 410 374
[NiL1L2Cl]Cl 1653 1596 1584 474 442 377
[CoL1L2Cl]Cl 1650 1572 1565 453 429 376
[FeL1L2(Cl)3] 1646 1579 1575 471 434 378
[ZnL1L2Cl] Cl 1638 1572 1569 478 447 375
Table 3 Electronic absorption spectral data of the complexes in DMSO solution.
Compound Solvent Absorption Molar extinction coeﬃcient, cm1 mol1 Band assignment Geometry
L1 DMSO 31300 – INCT –
L2 DMSO 28,996 – INCT –
[CuL1L2Cl]Cl DMSO 25935, 20823 250 98 INCT 2B1g ! 2A1g Square planar
[NiL1L2Cl]Cl DMSO 20213, 24,662 125 107 1A1g ! 1B1g and 1A1g ! 1B2g Square planar
[CoL1L2Cl]Cl DMSO 17648, 32751 132 155 1A1g ! 1Bg INCT Square planar
[FeL1L2(Cl)3] DMSO 18832, 19064 165 210
6A1g ! 4T1g(G) and 6A1g ! 4T1g(G) Octahedral
Table 1 Physical and analytical data of the synthesized complexes.
Compound Colour M. P Yield (%) Elemental analysis Molar conductance (O1cm2 mol1) leﬀ (BM)
C H N M
L1 Yellow 205 85 68.30 (68.2) 5.38 (5.37) 14.94 (14.92) – – –
L2 Yellow 227 81 59.36 (59.35) 3.20 (3.22) 14.84 (14.83) – – –
[CuL1L2Cl]Cl Dark Green 252 82 51.53 (51.54) 3.46 (3.47) 12.03 (12.01) 9.10 (9.08) 48 1.82
[NiL1L2Cl]Cl Pale Blue 185 78 51.89 (51.90) 3.49 (3.50) 12.11 (12.13) 8.46 (8.48) 51 Dia
[CoL1L2Cl]Cl Dark pink 198 82 51.87 (51.85) 3.49 (3.47) 12.11 (12.10) 8.49 (8.48) 32 4.1
[FeL1L2 (Cl)3] Dark Brown >240 80 49.56 (49.54) 3.33 (3.31) 11.57 (11.55) 7.69 (7.67) 8 5.8
[ZnL1L2Cl]Cl Dark Yellow 225 84 51.39 (51.40) 3.45 (3.43) 11.99 (11.97) 9.34 (9.36) 37 Dia
Metal based SOD mimetic therapeutic agents: Synthesis, characterization and biochemical studies of metal complexes 5bands, respectively. IR spectra of the ligands (L1 and L2) and
metal complexes are presented in Table 2.
4.3. Electronic absorption spectra
The electronic absorption spectra of the ligands and their com-
plexes were recorded in DMSO and presented in Table 3. In the
present study, the copper complex exhibited bands at 25, 935
and 20,823 cm1 which are assigned to 2B1g ! 2A1g transitions
characteristic of square planar geometry with dx2y2 ground state
(Iskander et al., 2000; Reddy et al., 2000; Lever, 1984 Dutta
et al., 1992). The magnetic moment value of 1.82 BM suggested
the square-planar geometry around Cu(II) ion.
The absorption spectrum of the nickel complex shows two
d-d bands at 20,213 and 24,662 cm1 which are assigned as
1A1g ! 1B1g and 1A1g ! 1B2g transitions, indicating square
planar geometry (Xu et al., 2003). This complex shows the dia-
magnetic behaviour suggesting the square planar environment
around the Ni(II) ion.
The electronic spectrum of Fe(III) complex exhibits bands
at 18,832 and 19,064 cm1 which may be due to
6A1g ! 4T1g(G) and 6A1g ! 4T1g(G) transitions, respectively.Please cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
biochemical studies of metal complexes. Arabian Journal of Chemistry (2These transitions are assigned for octahedral Fe(III) com-
plexes. The electronic transitions together with the magnetic
moment value of 5.8 BM suggested the octahedral geometry
for the Fe(III) complex.
The spectrum for Co(II) complex shows d–d bands at
17,648 and 32,751 cm1 may be assigned to 1A1g ! 1B1g and
n–p* respectively, in square planar stereochemistry. The mag-
netic moment value of 4.1 BM indicated the square planar
geometry for the Co(II) ion.
Zn(II) is a d10 metal ion, no band is expected in the visible
region and is also found as a diamagnetic complex, as ex-
pected. However, a strong band observed at 563 nm is assign-
able to the LﬁM charge transfer transition (Temel et al.,
2002) which is compatible with this complex having a square
planar geometry.
4.4. ESR spectra
ESR spectrum of the copper complex was recorded in DMSO at
300 and 77 K. The observed trend of
g||(2.28) > g^(2.05) > ge(2.0023) describes the axial symmetry
with the unpaired electron residing in the dx2y2 orbital (Hathawayased SOD mimetic therapeutic agents: Synthesis, characterization and
013), http://dx.doi.org/10.1016/j.arabjc.2013.07.024
6 J. Joseph, G. Ayisha Bibin Raniet al., 1970). The value of g|| < 2.3 in the present copper complex
gives a clear indicationof a covalent character of themetal–ligand
bond and delocalization of the unpaired electron into the ligand.
Researchers reported a good correlation between f factor
(f= g||/A||) and SOD like activity of copper complexes. The f
value for CuZn SOD is 160 cm indicating a tetrahedral distor-
tion from square planar geometry (f value is above 135 cm)
and one of the features that enhances the catalytic activity of
the enzyme. From the above EPR spectral data, the f values
for copper complex is observed at 150 cm. Therefore, our syn-
thesized copper complex exhibits appreciable square planar dis-
tortion that is expected to show high SOD like activity. The
EPR parameters g||, g^, A|| and the energies of d–d transition
were used to evaluate the bonding parameters a2, b2, c2 which
may be regarded as measures of the covalency of the in-plane
r bonds, in-plane p bonds and out-of-plane p bonds.
Molecular orbital coefﬁcients a2 (covalent inplane r-bond-
ing), b2 (covalent in- plane p- bonding) and c2 (out-plane p -
bonding) were calculated using the following equations:
a2 ¼ ðAjj=0:036Þ þ ðgjj  2:0027Þ þ 3=7ðg?  2:0023Þ
þ 0:04 ð2Þ
If the a2 value is 0.5, it indicates a complete covalent bonding,
while the value of a2 = 1.0 suggests a complete ionic bonding.
The observed value of a2 (0.75) indicates that the complex has
some covalent character.
b2 ¼ ðgjj  2:0027ÞE= 8ka2 ð3Þ
c2 ¼ ðgjj  2:0027ÞE= 2ka2 ð4Þ
The observed b2 and c2 values of 1.29 and 0.78 indicate that
there is an interaction in the out-of-plane g -bonding, whereas
the in-plane g -bonding is predominantly ionic. Signiﬁcant
information about the nature of bonding in the Cu(II) complex
can be derived from the relative magnitudes of K|| and K^.
Kjj ¼ a2b2 ð5Þ
K? ¼ a2c2 ð6Þ
For the present complex, the observed order K||
(0.96) > K^(0.585) implies a greater contribution from out-of
plane g -bonding than from in-plane g-bonding in metal–ligand
g bonding.
The empirical factor f= g///A// cm
1 is an index of tetrag-
onal distortion. Values of this factor may vary from 105 to 135
for small to extreme distortions in square planar complexes
and it depends on the nature of the coordinated atoms (Pogni
et al., 2000). The f values of complexes are found to be in the
range 137–154, indicating signiﬁcant distortion from planarity.
These values are shown in Table 4.
4.5. Mass spectra
The FAB mass spectra of the Schiff base and its metal com-
plexes are used to compare the stoichiometry compositions.Table 4 ESR spectral data of the copper complex.
Complex g|| g^ giso A|| A^
[CuL1L2Cl]Cl at 300 K – – 2.15 – –
[CuL1L2Cl]Cl at 77 K 2.28 2.05 – 152 41
Please cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
biochemical studies of metal complexes. Arabian Journal of Chemistry (2The Schiff base ligands L1 and L2 show a molecular ion peak
at m/z= 282 and 284. The molecular ion copper complex was
observed at m/z= 701 which shows the stoichiometry of the
complexes as supported by the FAB mass spectra of other
complexes. Elemental analysis values are in close agreement
with the values calculated from the molecular form of these
complexes, which is further supported by the FAB-mass stud-
ies of representative complexes.
4.6. DNA binding studies
4.6.1. Electronic absorption spectroscopy
Electronic absorption spectroscopy is performed to determine
the binding characteristics of the metal complex with DNA. In
UV region, two intense bands absorbed at 370 nm are attrib-
uted to the ligand to metal charge transfer absorption and an-
other at 265 nm which is assigned to the pﬁ p*transition of
aromatic chromophore. It has been reported that the interca-
lating ability of the complex depends on the planarity of li-
gands, the coordination geometry, ligand donor atom type
and the metal ion type (Terenzi et al., 2009). Intercalative
mode of binding results in hypochromism and red shift due
to the strong stacking interaction between an aromatic chro-
mophore and the base pairs of DNA. The extent of red shift
and hypochromism are found to correlate with the intercala-
tive binding strength.
Metal complexes which bind non-intercalatively or electro-
statically with DNA may result in hyperchromism. In cop-
per(II) complex the decrease in the absorption intensity
(hypochromism) with a slight red shift is due to the intercala-
tive binding between DNA and metal complexes. The absorp-
tion bands of complex at 265 nm shifted to 259, 257, 255 nm,
respectively, with increasing concentrations (40, 60, 80 lM).
4.6.2. Electro chemical studies
In the cyclic voltammetric (CV) study, mixed ligand complexes
were performed in the presence and absence of CT DNA and
are shown in Fig. 1. From the CV results, it could be found
that mixed ligand complexes exhibited a pair of redox peaks
for one electron transfer couple of Cu(II)/Cu(I) at the scan rate
of +2 to 2 V. The ratio of oxidation peak current to reduc-
tion peak current (Ipa/Ipc) of 0.5 and the peak-to-peak separa-
tion (DEp) of 0.26 suggested the characteristic of the electro-
transfer process, and this was fairly common for Cu(II)/
Cu(I) couple because of the reorganization of the coordination
sphere (Palaniandavar et al., 1995). After interaction with CT
DNA, the value of DEp was decreased to 0.20 V, suggesting
that the reversibility of the electron-transfer process of the cop-
per complex changed better. Both the oxidation and the reduc-
tion peak potentials underwent positive shifts accompanied by
the decreases of the redox peak currents. The electrochemical
potential of the small molecules would shift positively when
it intercalated into DNA double helix, and if it is bound to
DNA by electrostatic interaction, the potential would shift in
a negative direction (Carter et al., 1989). So, the positive shiftK|| K^ a
2 b2 c2 (f= g||/ A||)cm
– – – – – –
0.96 0.585 0.75 1.29 0.78 150
ased SOD mimetic therapeutic agents: Synthesis, characterization and
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Figure 1 Cyclic voltammogram of [CuL1L2Cl]Cl] in buffer pH = 7.2 at 25 C in the presence of increasing amount of DNA.
Table 5 Electrochemical parameters for the mixed ligand complexes on interaction with CT DNA.
Compound Redox couple aE1=2(V)
bDEp(V) Ipa/Ipc
Free Bound Free Bound
[CuL1L2Cl]Cl Cu(II)ﬁ Cu(I) 0.301 0.270 0.261 0.213 1.15
[NiL1L2Cl] Cl Ni(II)ﬁNi(I) 0.331 0.348 0.435 0.437 1.09
[CoL1L2Cl] Cl Co(III)ﬁ Co(II) 0.242 0.351 0.447 0.501 1.28
[FeL1L2 (Cl)3] Fe (III)ﬁ Fe(II) 0.218 0.310 0.439 0.486 1.26
[ZnL1L2Cl] Cl Zn(II)ﬁ Zn(0) 0.347 0.353 0.338 0.310 0.86
Table 6 IC50 values of some complexes and the native
enzyme.
S. no. Complex IC50 value (lM)
1 [CuL1L2Cl]Cl 98
2 [NiL1L2Cl]Cl 96
3 [CoL1L2Cl]Cl 87
4 [FeL1L2 (Cl)3] 93
5 [ZnL1L2Cl]Cl 85
6 Cu / Zn SOD 0.04
Metal based SOD mimetic therapeutic agents: Synthesis, characterization and biochemical studies of metal complexes 7of the redox potentials implied that the present mixed ligand
complex bind to DNA via an intercalation mode. The electro-
chemical parameters of mixed ligand complexes are shown in
Table 5.
4.7. Superoxide dismutase (SOD) mimic activities
Transition metal complexes have received much attention in
the development of superoxide dismutase (SOD) mimic activ-
ities for scavenging of the superoxide free radical ions (O2 )
(Patel et al., 2006; 2007; 2009). The SOD activity for the com-
plexes was tested using NBT assay. The SOD activities of these
complexes have been compared with those of the well known
native enzyme (Table 6) (Siddiqi et al., 2009, 2010, 2011;
Sorenson, 1984). The IC50 values for Cu(II), Ni(II), Co(II),
Fe(III) and Zn(II) complexes are found to be 98, 96, 87, 93,
85 lM respectively, indicating that the copper(II) complexes
showed good activity. These values may be due to the strong
ﬁeld created by the Schiff base ligand which opposes the inter-
action of coordinated copper with O2 radical. A greater inter-
action between superoxide ion and Cu(II) complex is induced
due to the stronger axial bond, which results in an increased
catalytic activity. In addition azomethine ligands containing
electron withdrawing substituent stabilizes the Cu(I) complex
formed during superoxide dismutation reaction which further
reacts with superoxide ion to give hydrogen peroxide. ThePlease cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
biochemical studies of metal complexes. Arabian Journal of Chemistry (2difference in reactivities of the synthesized complexes may be
attributed to the coordination environment and the redox po-
tential of the couple in metal complexes during the catalytic cy-
cle. It has been reported that the redox potential of copper(II)
ions is affected by the preset ligand system. The present Cu(II)
complexes have a distorted square planar geometry encourag-
ing a greater accessibility of the superoxide radical anion (O2 ).
Generally, metal-catalyzed superoxide dismutation is de-
scribed by the following two equations:
Cu2þ þO2 ! Cuþ þO2 ð7Þ
Cuþ þO2 þ 2Hþ ! Cu2þ þH2O2 ð8Þased SOD mimetic therapeutic agents: Synthesis, characterization and
013), http://dx.doi.org/10.1016/j.arabjc.2013.07.024
Table 7 Minimum inhibitory concentration of the synthesized compounds against growth of bacteria (lg/ml).
Compound E. coli K. pneumonia S. typhi P. aeruginosa S. aureus
L1 60 64 66 66 72
L2 58 62 58 59 69
CuCl2.2H2O 82 85 87 91 88
NiCl2.6H2O 66 74 81 85 83
CoCl2.6H2O 81 68 72 78 89
FeCl3.6H2O 79 82 86 82 91
ZnCl2 75 81 81 92 83
[CuL1L2Cl]Cl 51 54 52 61 62
[NiL1L2Cl]Cl 49 56 52 65 53
[CoL1L2Cl]Cl 51 55 61 63 51
[FeL1L2(Cl)3] 43 58 62 59 52
[ZnL1L2Cl]Cl 50 42 55 63 51
Pencillin 12 17 8 15 5
Ampicillin 15 13 5 2 8
Vancomycin 8 16 14 10 12
Oﬂoxacin 11 14 8 8 17
Table 8 Minimum inhibitory concentration of the synthesized compounds against growth of fungi (lg/ml).
Compound A. niger R .stolonifer A. ﬂavus R. bataicola C. albicans
L1 63 65 71 77 50
L2 51 65 53 67 52
CuCl2.2H2O 94 81 82 81 89
NiCl2.6H2O 86 75 71 72 82
CoCl2.6H2O 91 81 85 89 80
FeCl3.6H2O 87 88 82 72 71
ZnCl2 72 73 82 86 82
[CuL1L2Cl]Cl 29 34 33 33 27
[NiL1L2Cl] Cl 23 29 32 28 23
[CoL1L2Cl] Cl 18 22 31 21 17
[FeL1L2(Cl)3] 19 21 32 28 24
[ZnL1L2Cl] Cl 29 29 21 31 27
Nystatin 14 17 9 12 14
Kctoconazole 3 7 15 8 16
Clotrimazole 6 8 17 12 4
8 J. Joseph, G. Ayisha Bibin RaniThe results suggested that the superoxide scavenging proper-
ties and oxidative behaviour of mixed ligand complexes were
identical to those of complexes supporting the above
mechanism.
4.8. Antimicrobial activity
The in vitro biological screening effects of the investigated com-
pounds were tested against the bacterial species and fungal spe-
cies by the disc diffusion method. The minimum inhibitory
concentration (MIC) values of the synthesized compounds are
summarized in Tables 6 and 7. A comparative study of the me-
tal salts, ligands and their complexes (MIC values) indicates
that complexes exhibit higher antimicrobial activity than the
free ligands. The enhanced activity of the complexes can be ex-
plained on the basis of Overtone’s concept (Sabrina Belaida
et al., 2008) and Tweedy’s Chelation theory (Dharamaraj
et al., 2001). According to Overtone’s concept of cell permeabil-
ity, the lipid membrane that surrounds the cell favours the pas-
sage of only the lipid soluble materials which makes
liposolubility as an important factor, and which controls the
antimicrobial activity. On chelation, the polarity of the metal
ion will be reduced to a greater extent due to the overlap ofPlease cite this article in press as: Joseph, J., Ayisha Bibin Rani, G. Metal b
biochemical studies of metal complexes. Arabian Journal of Chemistry (2the ligand orbital and partial sharing of the positive charge of
the metal ion with donor groups. Further, it increases the delo-
calization of g-electrons over the whole chelate ring and en-
hances the lipophilicity of the complexes (Tumer et al., 1999).
The antimicrobial activity of the metal salts was also inves-
tigated. It was found that the metal salts exhibit antimicrobial
activity at the concentration range used to assay the activity of
the complexes but can be toxic. The toxic nature was reduced
by the incorporation of suitably substituted ligands instead of
chloride ion in the metal salts. This increased lipophilicity en-
hances the permeation of the complexes into lipid membranes
and blocking of the metal binding sites in the enzymes of
microorganisms. These complexes also disturb the respiration
process of the cell and thus block the synthesis of the proteins
that restricts further growth of the organism and as a result
microorganisms die. The increased activity of the complexes
may also be explained on the basis of their high solubility, ﬁt-
ness of the particles, size of the metal ion and the presence of
the bulkier organic moieties.
Furthermore, the mode of action of the compounds may in-
volve the formation of hydrogen bonds through the azome-
thine(C‚N) group of complexes with the active centres of
cell constituents resulting in the interference with normal cellased SOD mimetic therapeutic agents: Synthesis, characterization and
013), http://dx.doi.org/10.1016/j.arabjc.2013.07.024
Metal based SOD mimetic therapeutic agents: Synthesis, characterization and biochemical studies of metal complexes 9processes. The different lipophilic behaviour of the aromatic
residues such as antipyrine, and furfuraldehyde is involved in
the biological activity mechanisms. There are other factors
which also increase the activity are solubility, conductivity
and bond length between the metal and ligand (Mohamed
et al., 2009; Mahajan et al., 2009; chohan et al., 2001).
5. Conclusions
We have synthesized novel mixed ligand complexes with 4-
aminoantipyrine derivatives which were synthesized and char-
acterized by elemental analysis, spectral studies (FT-IR, UV–
Vis, 1H NMR, ESR). Antimicrobial activity studies showed
that the complexes have better biological activity as compared
to free ligands. This activity may be due to increased lipophil-
icity of the complexes. The mixed ligand complexes showed the
higher binding activity due to the presence of electron donat-
ing methyl group in the 4-aminoantipyrine. The DNA-binding
properties of mixed ligand complexes have been studied by
electronic absorption spectra and cyclic voltammetry. The ob-
served results suggested that the complexes were in interaction
with DNA through the intercalation binding mode. Among
the metal complexes, copper complex showed a higher scav-
enging ability for oxygen radical. We hope that the preliminary
studies have encouraged carrying out in vivo experiments and
maybe act as potential chemotherapeutic agents. Table 8.Acknowledgements
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